Session 2I: Examining TGR as a Drug Target against Human Schistosomiasis
Session Number
Session 2I: 2nd Presentation
Advisor(s)
Dr. David Williams, Rush University
Location
Room A119
Start Date
26-4-2018 10:35 AM
End Date
26-4-2018 11:20 AM
Abstract
Schistosomiasis is a waterborne, parasitic disease often found in underdeveloped areas in Africa, Southeast Asia, and South America that affects 260 million people worldwide. Currently, there is only one drug used to treat schistosomiasis, Praziquantel. However, scientists believe the worm may soon evolve resistance to the drug, as proven in a laboratory environment, stressing the need for another form of treatment.
Session 2I: Examining TGR as a Drug Target against Human Schistosomiasis
Room A119
Schistosomiasis is a waterborne, parasitic disease often found in underdeveloped areas in Africa, Southeast Asia, and South America that affects 260 million people worldwide. Currently, there is only one drug used to treat schistosomiasis, Praziquantel. However, scientists believe the worm may soon evolve resistance to the drug, as proven in a laboratory environment, stressing the need for another form of treatment.